Blood processing devices and consumables are used in diagnostic centers and blood banks for processing, storage and management of donated blood. These devices help in maintaining the blood components in their actual form for blood transfusion process, since any change in blood components can make it unusable.

A major factor driving growth of the global blood processing devices and consumables market is increasing number of blood transfusion procedures around the world. In addition, increasing incidences of chronic infections and rising number of road accidents is further boosting demand for blood processing devices and consumables in the global market. Moreover, increasing number of blood banks and hospitals is another factor expected to further propel growth of the global market to a significant extent over the forecast period.

The global market is segmented on the basis of product and region. On the basis of product, the global market is segmented into devices and consumables. The devices segment is further sub-segmented into plasma freezers, blood bank refrigerators, lab freezers, ultra-low temperatures, shock freezers, grouping analyzers, warmers, hematocrit centrifuges, and cell processors. The consumables segment is further sub-segmented into blood administration sets, blood bags, blood collection needles, blood collection tubes, blood filters, blood lancets, blood grouping reagents, blood coagulation reagents, hematology reagents, slides, sedimentation tubes, slide stainer, test tube racks, and vials.

Request Sample Copy of the Report: https://marketresearch.biz/report/blood-processing-devices-and-consumables-market/request-sample/

On the basis of region, the global market North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America accounts for highest revenue share in the global market and is expected to maintain its position over the next 10 years. The Asia Pacific blood processing devices and consumables market is expected to witness fastest growth over the forecast period.

Key players in the global market are Abbott Laboratories, Roche Holdings AG, Bio-Rad Laboratories, Becton, Dickinson and Company, Danaher Corporation, Immucor, Inc., Terumo Corporation, Grifols International, Haemonetics Corporation, Thermogenesis Corporation, Biomerieux SA, Macopharma SA, and other prominent players.